{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:57:07Z","timestamp":1722963427330},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/mpa.0000000000000459","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T10:17:11Z","timestamp":1444990631000},"page":"528-532","source":"Crossref","is-referenced-by-count":3,"title":["Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases"],"prefix":"10.1097","volume":"45","author":[{"given":"Michelle Kang","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.P.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasan","family":"Roayaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail","family":"Shafir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Itzkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors.","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-7-20210212","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000152000","article-title":"Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.","volume":"8","author":"Nikou","year":"2008","journal-title":"Pancreatology"},{"key":"R4-7-20210212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/ERC-12-0340","article-title":"Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.","volume":"20","author":"Ter-Minassian","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1136\/gut.2006.092320","article-title":"Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.","volume":"55","author":"Turner","year":"2006","journal-title":"Gut"},{"key":"R6-7-20210212","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/MPA.0b013e3181bc0e77","article-title":"Biochemical testing for neuroendocrine tumors.","volume":"38","author":"Vinik","year":"2009","journal-title":"Pancreas"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/03009739509178905","article-title":"The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.","volume":"100","author":"Stridsberg","year":"1995","journal-title":"Ups J Med Sci"},{"key":"R8-7-20210212","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/joe.0.1440049","article-title":"Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.","volume":"144","author":"Stridsberg","year":"1995","journal-title":"J Endocrinol"},{"key":"R9-7-20210212","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"R10-7-20210212","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXXATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J Clin Oncol"},{"key":"R13-7-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors.","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"R15-7-20210212","first-page":"876","article-title":"AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.","volume":"40","author":"Gloesenkamp","year":"2012","journal-title":"Int J Oncol"},{"key":"R16-7-20210212","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3748\/wjg.14.2461","article-title":"Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.","volume":"14","author":"Hopfner","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R17-7-20210212","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2007.13.6374","article-title":"Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R18-7-20210212","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/01635580902803719","article-title":"The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells.","volume":"61","author":"Ye","year":"2009","journal-title":"Nutr Cancer"},{"key":"R19-7-20210212","first-page":"4037","article-title":"Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"key":"R20-7-20210212","first-page":"495","article-title":"CDC25 phosphatases in cancer cells: key players Good targets Nat Rev Cancer.","volume":"7","author":"Boutros","year":"2007","journal-title":""},{"key":"R21-7-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/bcr277","article-title":"The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.","volume":"3","author":"Chiarle","year":"2001","journal-title":"Breast Cancer Res"},{"key":"R22-7-20210212","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.","volume":"68","author":"Roux","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"R23-7-20210212","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"R24-7-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4143\/crt.2013.102","article-title":"p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors.","volume":"46","author":"Kim","year":"2014","journal-title":"Cancer Res Treat"},{"key":"R25-7-20210212","first-page":"256","article-title":"Protein signature for non-small cell lung cancer prognosis.","volume":"4","author":"Liu","year":"2014","journal-title":"Am J Cancer Res"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:38:44Z","timestamp":1620963524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201604000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000459","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}